Clinical investigation of medicinal products for prevention of venous thromboembolism (VTE) in patients undergoing high VTE-risk surgery

  • Email
  • Help
Current effective version

Revision 2 - Adopted guideline

Reference numberEMA/CHMP/325170/2012 Rev.2
Published30/05/2013
Effective from30/11/2013
KeywordsCHMP, venous thromboembolic risk
DescriptionThis document provides guidance for the evaluation of new medicinal products in the primary prophylaxis of high intra- and post-operative venous thrombo-embolic risk.


Document history

Revision 2

Current version

Adopted guideline

 

Overview of comments

 

Draft guideline

 

Concept paper

In operation: 30/11/2013–present

 

Published: 30/05/2013

 

Published: 30/05/2012

 

Published: 01/07/2011

Revision 1

Adopted guideline

 

Overview of comments

 

Draft guideline

 

Concept paper

In operation: 31/05/2008–29/11/2013

 

Published: 15/11/2007

 

Published: 16/11/2006

 

Published: 17/11/2005

First versionPoints to considerPublished: 29/06/2000


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more